Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Clasificación en acciones #17273
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Precio por acción
$2.17
Capitalización bursátil
$249.58M
Cambio (1 día)
-1.67%
Cambio (1 año)
96.34%
País
CA
Comercio Cardiol Therapeutics Inc. (CRDL)

Categoría

Historial de desdoblamientos de acciones de Cardiol Therapeutics Inc. (CRDL)
La acción Cardiol Therapeutics Inc. (símbolo: CRDL) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 02, 2026.
Una acción CRDL comprada antes de Sep 02, 2026 equivaldría hoy a 0 acciones CRDL.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
JP
5 x119
IN
0 -
CH